MicroPort and Robocath to form China joint venture for vascular robotics

MicroPort and Robocath signed a binding term sheet to establish a China-based joint venture to obtain regulatory approval, manufacture, and commercialize Robocath's R-One robotic system in Greater China. MicroPort will invest €5.1 million for 51% stake, Robocath €4.9 million for 49%.

“The investment and joint venture enable the Group to become a shareholder of Robocath, thereby promoting cooperation with Robocath to commercialize its highly innovative vascular robotic platform in the Chinese market.”zhitongcaijing.com

• 1 source
• zhitongcaijing.com微创医疗(00853)拟战略入股血管机器人公司并参设合营企业Apr 29, 2020

Summarized from public sources; check the original articles before acting on it.